rediff.com
e.g. Tata motors, Reliance MF, 500570
Par Drugs & Chemicals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Sources of funds
Owner's fund
Equity share capital 12.30 12.30 6.15 6.15 4.48
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 58.93 47.57 46.06 34.46 24.64
Loan funds
Secured loans - - 7.64 4.62 6.55
Unsecured loans - - - - 3.80
Total 71.24 59.88 59.85 45.23 39.47
Uses of funds
Fixed assets
Gross block 67.57 60.02 52.54 34.40 56.71
Less : revaluation reserve - - - - -
Less : accumulated depreciation 29.12 25.91 22.63 - 20.37
Net block 38.45 34.10 29.91 34.40 36.34
Capital work-in-progress 0.25 0.25 4.52 0.74 -
Investments 0.01 0.01 0.01 0.06 0.06
Net current assets
Current assets, loans & advances 50.16 44.33 41.94 24.92 14.96
Less : current liabilities & provisions 17.63 18.81 16.53 14.88 11.89
Total net current assets 32.53 25.52 25.41 10.04 3.07
Miscellaneous expenses not written - - - - -
Total 71.24 59.88 59.85 45.23 39.47
Notes:
Book value of unquoted investments - - - 0.06 0.06
Market value of quoted investments - - - - -
Contingent liabilities - - 0.24 0.24 0.20
Number of equity sharesoutstanding (Lacs) 123.05 123.05 61.52 61.52 44.80
Close
Add Par Drugs & Chemicals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Par Drugs & Chemicals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close